Complementing these clinical findings, a groundbreaking Nature study by Harvard researchers (2025) demonstrated that reducing dietary lithium by more than 50% in Alzheimer’s mouse models accelerated amyloid-β and tau pathology, increased microglial activation, and led to synaptic loss and cognitive decline. The gene discussed is MAPT; the disease is Mental deterioration.